FDA Tackles 3-D Printing Considerations In Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
A draft guidance issued by FDA on additive manufacturing, or 3-D printing, of medical devices is meant to be a starting point for an industry that is growing exponentially. The document outlines recommendations on topics such as device design, software considerations and material testing requirements.